
pmid: 1402156
Ticlopidine, a new prototype antiplatelet agent, offers a significant alternative in the primary and secondary prevention of atherothrombotic stroke. While 2 multicenter trials demonstrated benefits of ticlopidine, this drug is not without risks and limitations and more studies are indicated. The neuroscience nurse must apply current knowledge about ticlopidine in the care for patients receiving ticlopidine therapy.
Blood Platelets, Cerebrovascular Disorders, Ticlopidine, Patient Education as Topic, Humans, Intracranial Embolism and Thrombosis, Intracranial Arteriosclerosis
Blood Platelets, Cerebrovascular Disorders, Ticlopidine, Patient Education as Topic, Humans, Intracranial Embolism and Thrombosis, Intracranial Arteriosclerosis
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
